Concepedia

Kobporn Lulu Howell

KL

Statistics

Publications

4

Citations

275

H-Index

4

Active since

2002

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Kobporn Lulu Howell is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, enzyme inhibition, and growth inhibition assays.

Publications per year

2002–2010

4

Publications

4

<i>N</i>-Hydroxy-3-phenyl-2-propenamides as Novel Inhibitors of Human Histone Deacetylase with in Vivo Antitumor Activity:  Discovery of (2<i>E</i>)-<i>N</i>-Hydroxy-3-[4-[[(2-hydroxyethyl)[2-(1<i>H</i>-indol-3-yl)ethyl]amino]methyl]phenyl]-2-propenamide (NVP-LAQ824)

Stacy Remiszewski, Lidia Sambucetti, Kenneth W. Bair et al. · Journal of Medicinal Chemistry · 2003 · 129 citations · Full text

, , +13

Inhibitors of Human Histone Deacetylase:  Synthesis and Enzyme and Cellular Activity of Straight Chain Hydroxamates

Stacy Remiszewski, Lidia Sambucetti, Peter Atadja et al. · Journal of Medicinal Chemistry · 2002 · 114 citations · Full text

, , +14

Spiroimidazolidinone NPC1L1 inhibitors. 1: Discovery by 3D-similarity-based virtual screening

Daniel R. McMasters, Margarita García‐Calvo, Vladimir N. Maiorov et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 16 citations · Full text

, , +14

Spiroimidazolidinone NPC1L1 inhibitors. Part 2: Structure–activity studies and in vivo efficacy

Kobporn Lulu Howell, Robert J. DeVita, Margarita García‐Calvo et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 16 citations · Full text

, , +10

1–4 of 4